Avadel Pharmaceuticals plc (AVDL)

6.75 -0.06 (-0.88%) At close: 04:00PM EDT

Avadel Pharmaceuticals plc

10 Earlsfort Terrace
Dublin 2
Ireland
353 1 901 5201
https://www.avadel.com

Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 66

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Gregory J. Divis Jr.	CEO & Director	862.59k	N/A	1967
Mr. Thomas S. McHugh	Sr. VP & CFO	550k	N/A	1965
Mr. Richard Kim	Chief Commercial Officer	596.3k	N/A	1969
Mr. Jerad G. Seurer	Gen. Counsel & Company Sec.	N/A	N/A	N/A
Mr. Gregory J. Davis	VP of Corp. and Bus. Devel.	N/A	N/A	1965
Mr. Mark W. Elrod	VP of Sales	N/A	N/A	N/A
Ms. Angie Woods	VP of People & Culture	N/A	N/A	N/A
Mr. Christian Kalita Pharm.D	Chief Pharmacist and Director of Quality Assurance & Regulatory Affairs	N/A	N/A	N/A
Mr. Steven G. Sullivan	VP of Sales & Marketing and Head of Commercial Operations	N/A	N/A	1965
Dr. Jordan S. Dubow M.D.	Consultant	N/A	N/A	1978

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.

Corporate Governance

Avadel Pharmaceuticals plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.